Announcements
- iRhythm Technologies to Report First Quarter 2024 Financial Results on May 2, 2024
- iRhythm Announces Closing of $661.25 Million of 1.50% Convertible Senior Notes Due 2029, Including Full Exercise of Initial Purchasers’ $86.25 Million Option to Purchase Additional Notes
- iRhythm Prices Upsized Offering of $575.0 Million of 1.50% Convertible Senior Notes Due 2029
- iRhythm Announces Proposed Offering of $450.0 Million of Convertible Senior Notes
- iRhythm collaborates with Epic to streamline access to Zio® service and drive more seamless connectivity between clinicians and patients
- iRhythm Technologies Announces Fourth Quarter and Full Year 2023 Financial Results
- iRhythm Technologies to Report Fourth Quarter and Full Year 2023 Financial Results on February 22, 2024
- iRhythm Technologies Shares Preliminary Fourth Quarter 2023 Highlights and Business Update at the 42nd Annual J.P. Morgan Healthcare Conference
- Largest Ever Real-World Evidence Study of Ambulatory Cardiac Monitoring Demonstrates Clinical Superiority of iRhythm's Zio Long-Term Continuous Monitoring Service
- iRhythm Technologies reçoit le marquage CE en vertu du règlement relatif aux dispositifs médicaux (règlement UE relatif aux DM) pour son moniteur Zio® et son système ZEUS
More ▼
Key statistics
As of last trade iRhythm Technologies Inc (I25:FRA) traded at 103.00, -15.57% below its 52-week high of 122.00, set on Apr 28, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 103.00 |
---|---|
High | 103.00 |
Low | 103.00 |
Bid | 103.00 |
Offer | 105.00 |
Previous close | 104.00 |
Average volume | 0.00 |
---|---|
Shares outstanding | 31.12m |
Free float | 30.88m |
P/E (TTM) | -- |
Market cap | 3.46bn USD |
EPS (TTM) | -4.04 USD |
Data delayed at least 15 minutes, as of Apr 26 2024 07:43 BST.
More ▼